STE

+ Watchlist + Portfolio

STERIS plc (Ireland)

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $236.91
52-Week Range: $195.14 – $269.44
Market Cap: $22.98B
P/E (TTM): 28.85
EPS (TTM): 8.17
Dividend Yield: 1.09%

Advanced Metrics

Price/Book: 3.19
PEG Ratio: 1.94
Return on Equity: 11.39%
Return on Assets: 6.80%
Gross Margin: 44.42%
Operating Margin: 19.15%
Profit Margin: 13.33%
Current Ratio: 1.91
Debt/Equity: 0.28
Total Debt: $2.04B
Free Cash Flow: $798.86M
Revenue Growth: 7.30%
Earnings Growth: 14.00%
Enterprise Value: $24.68B

STE Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$4.54B	$5.14B	$5.46B	$5.94B
Cost of Revenue	$2.56B	$2.92B	$3.06B	$3.31B
Gross Profit	$1.98B	$2.22B	$2.40B	$2.63B
Research & Development	$98.48M	$103.70M	$107.60M	$112.90M
Selling, General & Admin	$1.09B	$1.25B	$1.33B	$1.41B
Operating Expenses	$1.19B	$1.36B	$1.44B	$1.52B
Operating Income	$791.59M	$862.20M	$960.90M	$1.11B
EBITDA	$1.34B	$1.41B	$1.36B	$1.59B
Pretax Income	$680.27M	$702.80M	$796.20M	$1.05B
Income Tax	$124.07M	$149.50M	$184.70M	$262.20M
Net Income	$107.03M	$378.30M	$614.70M	$782.30M
Diluted EPS	1.07	3.81	6.20	7.93
Diluted Shares	100.25M	99.36M	99.07M	98.70M

STE Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$208.36M	$207.02M	$171.70M	$439.60M
Receivables	$864.99M	$1.01B	$1.04B	$1.09B
Inventory	$604.41M	$674.53M	$581.30M	$631.80M
Current Assets	$2.01B	$2.87B	$2.00B	$2.39B
Total Assets	$10.82B	$11.06B	$10.15B	$10.74B
Current Liabilities	$861.84M	$931.13M	$1.02B	$1.15B
Long-Term Debt	$3.02B	$3.12B	$1.92B	$1.81B
Total Debt	$3.25B	$3.38B	$2.20B	$2.09B
Total Liabilities	$4.73B	$4.75B	$3.53B	$3.54B
Retained Earnings	$1.91B	$2.09B	$2.48B	$3.02B
Shareholders' Equity	$6.08B	$6.30B	$6.60B	$7.18B
Working Capital	$1.15B	$1.94B	$978.60M	$1.25B
Net Debt	$2.87B	$3.00B	$1.87B	$1.49B

STE Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$756.95M	$973.30M	$1.15B	$1.34B
Capital Expenditure	-$361.97M	-$360.30M	-$370.10M	-$369.00M
Free Cash Flow	$394.98M	$613.00M	$778.00M	$972.40M
Stock-Based Compensation	$38.95M	$56.50M	$57.40M	$61.70M
Investing Cash Flow	-$383.33M	-$887.40M	$388.80M	-$512.50M
Financing Cash Flow	-$498.72M	-$85.20M	-$1.57B	-$568.20M
Dividends Paid	-$183.50M	-$200.60M	-$219.90M	-$241.80M
Share Repurchases	-$308.56M	-$11.80M	-$211.30M	-$235.50M
Net Change in Cash	-$125.10M	$700.00K	-$35.50M	$260.70M

STE Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$1.48B	$1.39B	$1.46B	$1.50B	$1.59B
Cost of Revenue	$839.32M	$763.10M	$814.40M	$840.70M	$891.20M
Gross Profit	$641.21M	$628.00M	$645.90M	$655.50M	$697.10M
Research & Development	$27.69M	$26.40M	$28.20M	$29.50M	$28.80M
Selling, General & Admin	$333.90M	$353.80M	$349.70M	$352.30M	$351.80M
Operating Expenses	$361.59M	$380.20M	$377.90M	$381.80M	$380.60M
Operating Income	$279.62M	$247.80M	$268.00M	$273.70M	$316.50M
EBITDA	$336.77M	$367.20M	$389.70M	$394.70M	$443.00M
Pretax Income	$197.31M	$231.90M	$253.10M	$257.80M	$304.50M
Income Tax	$50.45M	$53.90M	$60.60M	$63.50M	$84.20M
Net Income	$145.67M	$177.40M	$191.90M	$192.80M	$220.20M
Diluted EPS	1.48	1.79	1.94	1.96	2.24
Diluted Shares	98.76M	98.80M	98.80M	98.60M	98.40M

STE Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$171.70M	$279.70M	$319.20M	$423.70M	$439.60M
Receivables	$1.04B	$947.10M	$947.30M	$990.60M	$1.09B
Inventory	$581.30M	$641.20M	$658.50M	$673.50M	$631.80M
Current Assets	$2.00B	$2.06B	$2.11B	$2.29B	$2.39B
Total Assets	$10.15B	$10.40B	$10.41B	$10.59B	$10.74B
Current Liabilities	$1.02B	$926.60M	$888.90M	$922.30M	$1.15B
Long-Term Debt	$1.92B	$1.90B	$1.90B	$1.90B	$1.81B
Total Debt	$2.20B	$2.07B	$2.06B	$2.05B	$2.09B
Total Liabilities	$3.53B	$3.44B	$3.39B	$3.42B	$3.54B
Retained Earnings	$2.48B	$2.60B	$2.73B	$2.86B	$3.02B
Shareholders' Equity	$6.60B	$6.96B	$7.01B	$7.15B	$7.18B
Working Capital	$978.60M	$1.13B	$1.22B	$1.36B	$1.25B
Net Debt	$1.87B	$1.62B	$1.58B	$1.47B	$1.49B

STE Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$260.78M	$420.00M	$287.80M	$298.20M	$335.40M
Capital Expenditure	-$70.89M	-$93.60M	-$86.50M	-$98.70M	-$90.20M
Free Cash Flow	$189.90M	$326.40M	$201.30M	$199.50M	$245.20M
Stock-Based Compensation	$9.79M	$11.90M	$21.20M	$15.70M	$12.90M
Investing Cash Flow	-$69.80M	-$108.50M	-$88.30M	-$98.50M	-$217.20M
Financing Cash Flow	-$178.07M	-$213.10M	-$159.20M	-$98.00M	-$97.90M
Dividends Paid	-$56.01M	-$56.20M	-$61.90M	-$61.90M	-$61.80M
Share Repurchases	-$263.00K	-$10.60M	-$100.50M	-$50.10M	-$74.30M
Net Change in Cash	$12.91M	$98.40M	$40.40M	$101.60M	$20.30M

Market Snapshot

About

STERIS plc is a leading global provider of infection prevention, contamination control, surgical and critical care technologies and services. The company serves healthcare, pharmaceutical, research, and industrial customers with sterilization equipment, surgical instruments, and procedural products.